Suppr超能文献

一种新型抗糖尿病和抗血脂异常黄酮(S002 - 853)的质量控制与稳定性研究的测定方法。

Assay method for quality control and stability studies of a new anti-diabetic and anti-dyslipidemic flavone (S002-853).

作者信息

Naqvi Arshi, Pandey Anuja, Gupta Varsha, Malasoni Richa, Srivastava Akansha, Pandey Rishi Ranjan, Satyanarayana M, Pratap Ram, Dwivedi Anil Kumar

机构信息

Division of Pharmaceutics, Central Drug Research Institute, Lucknow, Uttar Pradesh, India.

Medicinal and Process Chemistry Division, Central Drug Research Institute, Lucknow, Uttar Pradesh, India.

出版信息

Pharmacogn Mag. 2015 May;11(Suppl 1):S53-9. doi: 10.4103/0973-1296.157689.

Abstract

BACKGROUND

Flavonoid-rich extract of the plant is long known for its anti-diabetic activities in traditional medicine. S002-853, a new flavone derivative synthesized by Central Drug Research Institute (CDRI) has been used for the present study.

OBJECTIVES

The present study aimed at development of an assay method for quality control (QC) and stability studies of a new anti-diabetic and anti-dyslipidemic agent CDRI compound S002-853.

MATERIALS AND METHODS

A validated high-performance liquid chromatography analysis method for S002-853 was developed for in process QC and stability studies. The separation was achieved on a RP-C18 (25 cm × 0.4 cm, 5 μm, Phenomenex) at 240 nm with flow rate of 1.0 ml/min. This method was applied successfully in establishing forced degradation and drug-excipient testing protocols as per International Conference on Harmonization guidelines.

RESULTS

The result of estimation and stress testing studies indicated a high degree of selectivity of this method. S002-853 was most stable at pH 7 and under photolytic conditions. The temperature degradation pattern of S002-853 was found to follow the zero order degradation.

CONCLUSION

The method described is easy and simple hence can be easily reproduced. This method can be very useful for bulk manufacture QC, and drug development process.

摘要

背景

该植物富含类黄酮的提取物在传统医学中因其抗糖尿病活性而久负盛名。本研究使用了由中央药物研究所(CDRI)合成的一种新型黄酮衍生物S002 - 853。

目的

本研究旨在开发一种用于新型抗糖尿病和抗血脂异常药物CDRI化合物S002 - 853质量控制(QC)和稳定性研究的分析方法。

材料与方法

开发了一种经过验证的用于S002 - 853的高效液相色谱分析方法,用于过程质量控制和稳定性研究。分离在RP - C18(25 cm×0.4 cm,5μm,菲罗门公司)上进行,检测波长为240 nm,流速为1.0 ml/min。该方法已成功应用于按照国际协调会议指南建立强制降解和药物 - 辅料测试方案。

结果

含量测定和强制降解研究结果表明该方法具有高度的选择性。S002 - 853在pH 7和光解条件下最稳定。发现S002 - 853的温度降解模式遵循零级降解。

结论

所描述的方法简便易行,因此易于重现。该方法对于批量生产质量控制和药物研发过程可能非常有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b52f/4461968/f0c56c83ed49/PM-11-53-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验